KeyBanc reiterates Sector Weight on SpaceX stock amid capex pressure

KeyBanc reiterated Sector Weight on SpaceX and left its price target unchanged, citing $23 billion in trailing-12-month revenue and forecast sales growth of 47% this year, offset by capex pressure and negative levered free cash flow of $32.5 million in the most recent period. The firm raised capex estimates for AI infrastructure, V3 satellite deployment, and Starship, viewing the investment as supportive of long-term revenue potential; Starship cadence and reusability remain key near-term drivers. Separately, Q3 2026 results reportedly beat expectations: EPS was $0.35 versus $0.13 forecast, revenue was $14.58 billion versus $12.87 billion, and net income was $4.4 billion versus a $1.1 billion year-earlier loss.

Analysis

The key underwriting issue is whether earnings strength converts into durable free cash flow or is being reinvested into a much larger capital base. A higher compute and launch-investment run rate can support future capacity, but it also raises the hurdle for incremental returns: if AI infrastructure utilization or Starship reuse cadence lags, depreciation and funding needs can outpace monetization. That would make the equity more sensitive to execution and valuation than headline growth suggests. Competitively, scaling internal compute could reduce dependence on external capacity, while drawing on the same constrained inputs—advanced chips, power, and engineering talent—as other AI infrastructure builders; the article does not establish SpaceX’s supplier exposure or project returns.

The near-term catalyst is evidence of Starship cadence and reuse, alongside updates on capex, utilization, and cash conversion over the next 1–3 months. Over 6–18 months, successful reuse and productive compute deployment could expand addressable markets; delays or weak returns would raise the risk of multiple compression. The earnings beat alone is not proof of that outcome. Also verify the financial scopes and periods: the cited LTM revenue and quarterly revenue figures do not reconcile on their face, so they should not be combined. The promoted fair-value estimate is not independent evidence of mispricing. Contrarian read: strong reported profitability may distract from the capital intensity, but the small cited negative levered FCF figure is not enough by itself to establish a severe cash-flow problem.

Key Decisions for Investors

• Do not chase the earnings reaction on headline beats alone. Treat SPCX as a watch/hold pending reconciliation of reported revenue periods and confirmation of capex, cash flow, and segment-level returns in company materials.
• For a 1–3 month catalyst trade, add only after evidence of improving Starship cadence/reuse and compute utilization; otherwise prefer no position over a short based solely on the current article. Reassess if capex rises without corresponding revenue or cash-conversion improvement.
• Falsify the cautious view if successive disclosures show sustained cash conversion alongside expanding deployment cadence and no material deterioration in unit economics. Falsify the bullish execution case if Starship milestones slip or compute investment continues to rise without disclosed utilization and monetization progress.